This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization